---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-008745"
form_type: "8-K"
ticker: null
cik: "0000316253"
company_name: "ENZO BIOCHEM INC"
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T11:45:07.347018+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enzo Biochem names permanent CEO and CFO; shareholders reject say-on-pay

## Summary
- Kara Cannon appointed permanent CEO (was interim since Sept 2023); Patricia Eckert appointed permanent CFO.
- Shareholders elected directors Pully, Radoff, Tagliaferri, Cannon; Radoff and Tagliaferri had narrow margins.
- Non-binding advisory vote on executive compensation rejected: 13.9M for vs 17.3M against.
- Shareholders ratified EisnerAmper as independent auditor for FY2024 ending July 31, 2024.
- 44.4M shares (87.94%) represented at meeting; quorum present.

## SEC filing metadata
- accession: 0001213900-24-008745
- form_type: 8-K
- cik: 0000316253
- company_name: ENZO BIOCHEM INC
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/ea192624-8k_enzobiochem.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-008745
- JSON: https://secwatch.observer/filing/0001213900-24-008745.json
- Plain text: https://secwatch.observer/filing/0001213900-24-008745.txt

## Key facts
- Executive change
  Kara Cannon was appointed as Chief Executive Officer at ENZO BIOCHEM INC.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On January 31, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Kara Cannon to serve as the Chief Executive Officer of the Company and Patricia Eckert, CPA, to serve as the Chief Financial Officer of the Company, in each case, until her successor is duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm
- Executive change
  Patricia Eckert was appointed as Chief Financial Officer at ENZO BIOCHEM INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On January 31, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Kara Cannon to serve as the Chief Executive Officer of the Company and Patricia Eckert, CPA, to serve as the Chief Financial Officer of the Company, in each case, until her successor is duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm
- Shareholder Votes
  ENZO BIOCHEM INC shareholders rejected Approval, by a nonbinding advisory vote, of the compensation of the Company's named executive officers.
  - Proposal: say on pay
  - Outcome: failed
  source text: The shareholders of the Company did not approve, by a nonbinding advisory vote, the compensation of the Company's named executive officers, as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm
- Shareholder Votes
  ENZO BIOCHEM INC shareholders approved Ratification of the Company's appointment of EisnerAmper LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending July 31, 2024 at the 2024-07-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-07-31
  source text: The shareholders of the Company ratified the Company's appointment of EisnerAmper LLP to serve as the Company's independent registered public accounting firm for the Company's fiscal year ending July 31, 2024, as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm
- Shareholder Votes
  ENZO BIOCHEM INC shareholders approved Election of Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to the Board.
  - Proposal: director election
  - Outcome: passed
  source text: The shareholders of the Company elected each of Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to serve on the Board for a term ending as of the Company's 2024 Annual Meeting of Shareholders, and until each such director's successor is elected and qualified, as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/316253/000121390024008745/0001213900-24-008745-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.